HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murkin, J. M. Articles by Wong, C. J. Search for Related Content PubMed PubMed Citation Articles by Murkin, J. M. Articles by Wong, C. J.

J Thorac Cardiovasc Surg 1995;110:349-362
© 1995 Mosby, Inc.

CARDIOPULMONARY BYPASS, MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES

A RANDOMIZED STUDY OF THE INFLUENCE OF PERFUSION TECHNIQUE AND pH MANAGEMENT STRATEGY IN 316 PATIENTS UNDERGOING CORONARY ARTERY BYPASS SURGERY:II. Neurologic and cognitive outcomes

London and Ottawa, Ontario, and Vancouver, British Columbia, Canada

Supported by grant A1498 from the Heart and Stroke Foundation of Ontario.

Presented in part at the Fiftieth Annual Meeting of the Canadian Anaesthetists Society, Halifax, Nova Scotia, Canada, June 1993.

Received for publication Sept. 1, 1994. Accepted for publication Dec. 22, 1994. Address for reprints: John M. Murkin, MD, Department of Anaesthesia, University Hospital, 339 Windermere Road, London, Ontario, Canada N6A 5A5

Abstract

This double-blind, randomized comparison of pulsatile or nonpulsatile perfusion and alpha-stat or pH-stat management during cardiopulmonary bypass was designed to assess postoperative central nervous system outcomes. Methods: Neurologic and cognitive testing was conducted before the operation and 7 days and 2 months after the operation in 316 patients having coronary artery bypass and in a reference cohort of 40 patients having major vascular and thoracic operations. Results: As detailed in part I of this study, mortality in patients having coronary bypass was 2.8%. The incidence of stroke was 2.5% and did not differ among bypass groups. Mortality was 2.5% for the major surgery cohort. The incidence of cognitive (p = 0.003) and either neurologic or cognitive dysfunction (p = 0.0002) was higher at 7 days for the coronary bypass group than for the major surgery cohort. The incidence of neurologic dysfunction remained higher (p = 0.050) at 2 months in the coronary bypass group. Cognitive dysfunction at 2 months was less prevalent after 90 minutes of cardiopulmonary bypass in patients managed with alpha-stat than with pH-stat strategy (27% versus 44%, p = 0.047). Conclusions: Postoperative central nervous system dysfunction is more prevalent in patients having coronary bypass than in those having major operations. Pulsatility has no effect on central nervous system outcomes, but alpha-stat management is associated with a decreased incidence of cognitive dysfunction in patients undergoing prolonged cardiopulmonary bypass. (J THORAC CARDIOVASC SURG 1995;110:349-62)

In part because of advances in alternate therapies, the average age, incidence of concomitant disease, and degree of atherosclerotic disease in patients presenting for coronary artery bypass (CAB) surgery have been increasing significantly over the past decade. ¹ In an assessment of more than 2000 patients undergoing CAB operations, advanced age was the greatest risk factor for postoperative neurologic dysfunction. ² In addition to age, studies have demonstrated that longer duration of cardiopulmonary bypass (CPB) also increases the risk of postoperative cognitive dysfunction. ^3-5 Increasingly, patient deaths have been attributed to postoperative neurologic injury. From 1970 to 1973, 8% of patients with CAB died after an adverse neurologic event; by contrast, from 1980 to 1983, 20% of postoperative deaths were attributable to neurologic injury. ⁶

At the same time a high incidence of subtle neurobehavioral dysfunction has been identified. Overall, the incidence of cognitive dysfunction after CAB operations has been demonstrated to range from 24% to 79% in the postoperative period ^3,4,7,8 and averages 35% at post-discharge follow-up, ^4,9 with 35% of patients still having cognitive impairment 12 months after the operation. ⁵

Previous studies have demonstrated the influence of pH management strategy ^10-12 and perfusion technique ^13,14 on cerebral blood flow during CPB. However, relatively few studies have assessed their impact on postoperative patient outcomes. ^15-18 Accordingly, the current study was designed to determine the influence of alpha-stat or pH-stat pH management and pulsatile or nonpulsatile perfusion during CPB on postoperative neurologic and cognitive functioning in a group of patients undergoing CAB surgery.

In addition, to better define the role of exposure to CPB in the genesis of postoperative central nervous system (CNS) dysfunction, a reference cohort of patients undergoing major thoracic or abdominal aortic procedures, but not cardiac operations, termed the noncardiac surgical cohort, underwent identical cognitive and neurologic examinations at similar intervals.

METHODS

Study objective
This is part II of a two-part study, part I appearing elsewhere in this JOURNAL. ¹⁹ The primary objective of this double-blind, randomized, clinical trial was to compare the impact of different pH management strategies and perfusion techniques during CPB on the incidence of cognitive and neurologic dysfunction in patients after CAB surgery. Secondarily, these results were compared with the incidences of CNS dysfunction in a group of patients undergoing major noncardiac operations. Study group characteristics, protocol-related inclusion and exclusion criteria, and details of pH management and perfusion technique during CPB are described in part I. ¹⁹

Reference cohort
To more clearly identify the risk of postoperative dysfunction as related to CPB—independent of undergoing a major surgical procedure—a noncardiac surgical cohort of 40 patients undergoing either abdominal aortic surgery (n = 27) or thoracic surgery (n = 13) underwent the same standardized preoperative and postoperative neurologic and cognitive assessments.

Neurologic assessment
A standardized neurologic examination assessing mentation, cranial nerve function, motor power, reflexes, sensation/cerebellar function, and gait, with 14 individual elements graded on a scale from 0 to 3 for a possible total of 42 (Table I; see also Appendix I for description), was performed within 24 hours after the operation, at 7 days after the operation, and at a 2-month follow-up visit, by a qualified nurse specialist. A score of less than 3 on any of the applicable elements on baseline assessment was identified as indicating preoperative neurologic dysfunction. The criterion for defining postoperative neurologic dysfunction was a decrease from baseline of individual elements totaling 2 or more points, representing either mild decrease in performance in two areas or significant decrease in one area.

Cognitive dysfunction
Failure to show progressive improvement in cognitive test performance over time ("learning effect") is a highly sensitive marker of minimal dysfunction and has been used by Sotaniemi, Mononen, and Hokkanen ²⁰ to define late dysfunction after cardiac operations. To define postoperative cognitive dysfunction and to control for the learning effect, we recruited a nonhospitalized group of 41 age and gender matched volunteers (a normative control group) to undergo the same cognitive battery at similar intervals as the treatment groups. Change scores from baseline were computed for each cognitive test, and a distribution of change scores was compiled for the normative control group to provide a range of "normal" variability in change scores that was specific for each domain (test) at each point. Cutoffs for "abnormal" functioning in the study groups were operationally defined as change scores that were exceeded by 95% (39 members) of the normative control group. ²¹ Values used as cutoffs for defining abnormal performance among the surgically treated patients are presented in Table II. Cognitive dysfunction was defined as impaired performance within one or more of the four areas assessed.

To standardize the influence of repeated neuropsychologic testings, we included only results from patients who underwent cognitive testing at 7 days in the 2-month follow-up analysis. Cognitive testing from patients not completing any or all components of the cognitive battery were not included in the analyses of cognitive outcomes unless their performance on that portion of the testing completed was impaired relative to their baseline level of performance.

Log-linear model analysis was first performed to ensure that no interaction existed between pH management, perfusion technique, and outcome events. Outcome events were compared between treatment groups by means of the ² test. Fisher's two-tailed exact test was used if the expected cell sizes were small. Demographic characteristics were assessed similarly for categoric variables. Two-way factorial analysis of variance was used to examine continuous variables and to confirm that pH management did not interact with perfusion technique. No adjustments were made for multiple comparisons. Logistic regression analysis was applied to examine potential risk factors for neurologic and cognitive dysfunction.

RESULTS

A total of 316 patients undergoing CAB operations were enrolled in this study. On average, slightly more than two patients were enrolled weekly, constituting approximately 30% of all patients undergoing CAB during this period. Demographic and clinical characteristics of the 316 patients in the study and the 40 patients in the noncardiac surgical cohort are shown in Table III. Other than significantly greater numbers of women in the major surgery cohort, there were no other differences in identifiable risk factors between patients having CAB and the reference cohort. Intended treatments during CPB were achieved such that there were appropriate and significant differences in arterial pH and arterial carbon dioxide tension between pH management groups and in pulse pressure between the pulsatile and nonpulsatile groups (Table IV).

Table V presents summary statistics for patients in the CAB and noncardiac surgical groups on measures of neurologic and cognitive functioning at baseline and 7 days and 2 months after the operation. Classification of patients as exhibiting neurologic or cognitive impairment resulted in an incidence of neurologic dysfunction that ranged from 28% to 33% and cognitive dysfunction that ranged from 78% to 80% at 7 days across the four CAB treatment groups (p = NS; see Table VI). The incidence of any dysfunction (either neurologic or cognitive impairment) ranged from 82% to 87% (p = NS). At 2 months' assessment, the incidence of neurologic impairment had decreased to 17% to 18% and the incidence of cognitive impairment had decreased to 30% to 36% across the four groups. Of the 316 patients enrolled at the time of the 7-day assessment, 26 refused or were unavailable for either cognitive or neurologic testing, 15 patients underwent neurologic but not cognitive testing, a further 2 patients had incomplete cognitive testing, and 1 underwent cognitive but not neurologic assessment. At the 2-month follow-up assessment, 39 patients were unavailable for any testing, and 1 underwent cognitive but not neurologic assessment. A further 4 patients did not undergo any cognitive assessment, 26 were excluded from analysis of cognitive performance because of the lack of a 7-day cognitive assessment, and 8 were excluded from analysis for cognitive assessment because of incomplete cognitive testing at follow-up. Surviving patients who did not complete 7-day or 2-month assessments were similarly distributed among all four treatment groups for all circumstances associated with unavailability or exclusion (NS according to ² test).

Duration of CPB had been identified at the inception of the study as one of the uncontrolled variables of interest. Moreover, past research has identified duration of CPB as a risk factor for negative CNS outcome. ^3-5 In our study, longer duration of CPB was found to be associated with increased CNS dysfunction. Post-hoc analysis was therefore undertaken to examine whether potential cerebroprotective effects of a given perfusion technique or pH management strategy would be most pronounced in those individuals undergoing CPB for a longer duration. Because mean duration of CPB was approximately 90 minutes, patients were arbitrarily grouped on the basis of CPB duration of less than or greater than 90 minutes, and neurologic and cognitive outcomes were analyzed according to CPB duration. The number of patients included in the long CPB duration group (CPB > 90 minutes) did not differ across treatment groups (41 alpha/pulse; 46 alpha/nonpulse; 42 pH/pulse; 45 pH/nonpulse; NS according to ² test). Results of this post-hoc analysis revealed that for patients undergoing CPB of 90 minutes' duration or longer, the incidence of cognitive dysfunction was significantly (p = 0.047) lower at 2 months (Table VII, Fig. 1) in the alpha-stat group than in the pH-stat group.

View larger version (18K): [in this window] [in a new window]   Fig. 1. Incidence of cognitive dysfunction 2 months after the operation for all patients in the CAB group and for those in whom CPB duration was 90 minutes or greater, excluding those in whom 7-day assessment was not available.

Factors identified by univariate analysis as significant, or as trending toward significance, were examined multivariately in a stepwise fashion. For either cognitive or neurologic dysfunction, significant correlations with increased age (p = 0.0010), longer duration of CPB (p = 0.0053), increased weight (p = 0.0065), and more years of education (p = 0.0017) were found at 7 days. At 2 months' follow-up, increased age (p = 0.0007) and presence of insulin-dependent diabetes mellitus (p = 0.0242) showed significant correlations with CNS dysfunction.

Neurologic and cognitive dysfunction in CAB versus noncardiac surgical cohort
Seventy-three percent (29/40) of patients in the noncardiac surgical cohort and 67% (211/316) of patients in the CAB group (p = NS) demonstrated preoperative neurologic abnormalities. In a younger group of 312 patients undergoing CAB, Shaw and associates ³ detected preoperative neurologic abnormalities in over 35%, whereas Carella and colleagues ⁷ found preoperative neurologic signs in 57.5% of patients in the CAB group. At 7-day assessment the trend was toward a higher incidence of neurologic dysfunction (p = 0.085) and a significantly higher incidence of cognitive dysfunction (p = 0.003) and of either cognitive or neurologic dysfunction (p = 0.0002) in the CAB group compared with the noncardiac surgical cohort. At 2 months the incidence of neurologic dysfunction was higher in the CAB group (p = 0.050), although the incidence of cognitive dysfunction did not differ between groups. Overall results are shown in Table VIII and Fig. 2.

View larger version (38K): [in this window] [in a new window]   Fig. 2. Percentage incidence of neurologic and cognitive dysfunction in CAB group and noncardiac surgical cohort 7 days and 2 months after the operation.

Although the etiology of postoperative CNS dysfunction is likely multifactorial, microgaseous and particulate emboli are particularly culpable. ^22-24 Equipment modifications such as arterial line filtration and use of membrane versus bubble oxygenators can decrease embolic load, ^22,23 although emboli are not entirely eliminated. Duration of CPB, as shown here and previously, ^3-5 is an independent risk factor for postoperative neurologic and cognitive dysfunction. Therefore, the positive impact of protective strategies would likely be most apparent in patients undergoing CPB of prolonged duration, who are exposed to a greater embolic load. Post-hoc subanalysis of the CAB study groups, as a function of duration of CPB with prolonged CPB defined as 90 minutes or greater, demonstrated a lower incidence of cognitive dysfunction at 2 months for the group managed with alpha-stat pH management.

pH management strategies
Alpha-stat management has been shown to preserve cerebral flow/metabolism coupling such that hypothermia-induced decreases in metabolic rate are accompanied by proportionate decreases in cerebral blood flow. ^4,10,17 In contrast, the increased carbon dioxide associated with pH-stat management induces cerebral vasodilatation and hyperemia resulting from pressure-passive changes in cerebral blood flow. ^10-12,17 The decreased incidence of cognitive dysfunction demonstrated 2 months after the operation in the alpha-stat group undergoing prolonged CPB is consistent with the hypothesis that fewer emboli are delivered into the cerebral circulation because of the proportionate decrease in cerebral blood flow relative to that of the pH-stat group.

In one of the few randomized studies of the influence of pH management strategy on postoperative neuropsychologic functioning reported to date, 86 patients with cardiac disease were assessed, and no difference in incidence of postoperative cognitive dysfunction between alpha-stat and pH-stat management was demonstrated. ¹⁵ In that study, however, no stratification for duration of CPB was made when results were analyzed, patients undergoing both open and closed chamber procedures were included, unfiltered bubble oxygenators were used, and pH-stat may not have been achieved in the treatment group. ²⁵ Lack of a clear outcome benefit in those circumstances may reflect the effect of exposure to much greater numbers of emboli in comparison with patients in whom a filtered CPB circuit is used. ²⁶ In addition, minimal differences in cerebral blood flow (and thus delivery of emboli into cerebral circulation) may have been present between their groups because of the small difference in actual arterial carbon dioxide tension (less than half that predicted). ^25,27 In contrast, a study of 65 patients by Stephan and coworkers ¹⁷ demonstrated improved neurologic outcome with alpha-stat pH management. They used membrane oxygenators and arterial line filtration in patients undergoing CAB operations and performed a neurologic examination before the operation and 7 days after the operation. Although cognitive testing was not performed on these patients, a higher incidence of neurologic dysfunction was found in patients in whom the pH-stat strategy (10/35) had been used than was found in those managed by the alpha-stat strategy (2/30). The 7% incidence of neurologic impairment reported in their alpha-stat group is lower than that which we observed (33%), however, and may reflect both differences in neurologic examination technique and their use of a younger study population (mean age 56 years, eldest aged 68 years). As demonstrated here and in other series, neurologic complications rise disproportionately with increased age. ^1,2 Finally, Patel and colleagues ¹⁸ used a standardized battery of 10 neuropsychologic tests before the operation and 6 weeks after the operation in a series of 70 patients undergoing CAB and randomized to alpha-stat or pH-stat strategies during nonpulsatile hypothermic CPB. They also demonstrated a significantly lower incidence of cognitive impairment 6 weeks after the operation (20% versus 48.6%, respectively) in the patients in whom alpha-stat management was used, incidences similar to our results.

Perfusion techniques
Although by no means universal, nonpulsatile perfusion has remained the most common mode of perfusion during CPB. Increases in cerebral blood flow and improved cerebral perfusion in the presence of cerebral ischemia ^13,28 were factors leading to our decision to test the CNS effects of pulsatile perfusion in the current study. No significant differences in neurologic or cognitive outcome were apparent with the use of pulsatile perfusion in this study, however, similar to what has been reported by Henze, Stephan, and Sonntag. ¹⁶ This may reflect either that pulsatility is not important in influencing CNS outcome after CPB or that the characteristics of the pulsatile perfusion generated during CPB are insufficient to significantly influence postoperative brain function. We did, however, observe a significantly lower mortality rate and lower incidences of cardiovascular complications in the pulsatile perfusion group (see part 1 of this study), ¹⁹ similar to the results reported by Taylor and associates. ²⁹

Noncardiac surgical cohort
Although interest in neurologic dysfunction after CAB operations has been increasing, relatively few studies have incorporated a noncardiac surgical cohort to help isolate risk factors associated with CPB, independent from that of undergoing a major surgical procedure. Shaw and colleagues ³ demonstrated an increased incidence and severity of postoperative cognitive dysfunction in patients having CAB compared with a reference cohort of 50 patients undergoing peripheral vascular surgery (79% versus 31%) when assessed before hospital discharge, similar to our findings. The results of Smith ⁴ are also consistent with our results in that at 8 days after the operation the incidence of moderate or severe cognitive deficit was significantly higher in a group of 67 patients having CAB, 73% versus 50%, respectively, than in a reference cohort of 24 patients having major vascular and non-CPB thoracic surgery. At 8 weeks after the operation, however, the incidences of neuropsychologic dysfunction were similar between groups at 37% and 44%, respectively. It was believed that different causes were involved in the genesis of impairment between the two groups, because patients in the reference cohort were older, had more extensive metabolic derangements (e.g., renal failure), and required more extensive pharmacologic support. Similarly, Hammeke and Hastings ⁸ reported that at 6 months postoperatively, the incidence of cognitive dysfunction was comparable in both a group of 24 patients having CAB and a group of eight patients having peripheral vascular surgery; this study was criticized, however, because some of the tests used were not suitable for repeat assessments and because of the small number of patients available at follow-up. ³⁰ We also found a significantly higher incidence of cognitive dysfunction at 7 days and no difference in incidence of cognitive dysfunction at 2 months, but we did demonstrate a significantly higher incidence of postoperative neurologic dysfunction at 2 months (17% versus 3%), in comparison with a noncardiac surgical cohort. Notably, none of the aforementioned studies assessed postoperative neurologic function.

The current results suggest that CAB operations are associated with a significantly greater incidence of cognitive dysfunction in the early postoperative period and a greater incidence of neurologic dysfunction at follow-up than are operations in which CPB is not used. The high incidence of preoperative neurologic abnormalities detected in both the CAB and the surgical cohort, and the similar incidences of cognitive dysfunction in both groups at 2 months after the operation, also suggests that these patients may have a particular susceptibility to CNS dysfunction because of associated disease processes (e.g., incipient cerebrovascular atherosclerosis). This susceptibility may render them at greater risk from all procedures involved with major surgery (e.g., sedation/analgesics, intensive care management) rather than cardiac surgery exclusively.

As proposed by Strittmatter and associates, ³¹ patients with apolipoprotein E- 4 genotypes demonstrate impaired neuronal reparative processes and are at increased risk of earlier onset of Alzheimer disease. These genotypes also appear to be at slightly increased risk of atherosclerosis and coronary artery disease ³² and thus may form a group that may be more susceptible to CNS injury. This is consistent with preliminary data from Tardiff and coworkers, ³³ which demonstrated a correlation between apolipoprotein E- 4 profile and cognitive dysfunction in patients undergoing CPB.

Additionally, cognitive dysfunction at 2 months is less prevalent after 90 minutes of CPB in patients managed with alpha-stat than with pH-stat strategy. This finding was obtained on a post-hoc analysis and, although consistent with findings of some prior research, ^17,18 it is subject to replication in future prospective studies. Finally, our results suggest that both neurologic and cognitive measures contribute uniquely to estimates of post-CPB morbidity. Thus concomitant assessment of both parameters is necessary to more fully quantify postoperative CNS dysfunction.

We are indebted for the support and cooperation of cardiac surgeons G M. Guiraudon, F. N. McKenzie, A. M. Menkis, and R. J. Novick, perfusionists A. Cleland, M. Henderson, R. Mayer, and J. MacDonald, and anesthesia research technician P. Lok. The assistance of D. A. Sim, D. Sharma, and P. Campbell in the initial stages of this project is also acknowledged.

Appendix: APPENDIX I (WESTERN PERIOPERATIVE NEUROLOGIC SCALE—GUIDE)

This scale is designed to detect and quantify anatomically discrete neurologic abnormalities. It is not intended as an assessment of neurologic functioning. Test/re-test reliability of the neurologic examination was demonstrated by having the same examiner administering the same structured neurologic examination over a 7-day interval to a group of 28 patients convalescing in the hospital for more than 1 month after CVA (intraclass correlation coefficient = 0.986).

Mentation
Level of consciousness:
Assessment of patient orientation, concentration, memory, and mental functioning. Orientation is based on the patient's awareness of time, place, and person where person refers to the patient as able to give name and address, place to identify the city and or name of the hospital, and time where the patient must give at least the correct month and year. If early in the month (i.e., first 3 days) previous month is acceptable. Speech may be dysarthric (mispronounced or slurred) but intelligible. If for any reason the patient cannot answer specific questions on orientation (i.e., does not know the answer, gives the wrong answer, answers only partially, cannot express himself or herself either by lack of words or unintelligible speech or finally ignores questions), he or she is considered disoriented.

3. Normal: Normal consciousness, fully conscious. The patient is alert, attentive, aware, and appropriate.

2. Drowsy: The patient when stimulated remains awake and alert for a short time but tends to doze off even during the examination. Lethargic but mentally intact.

1. Stuporous: The patient is obtunded, responds to loud verbal stimuli and/or strong touch; may vocalize but does not become alert or completely awake.
   
2. Comatose: The patient responds to deep pain such as sternal pressure, but (1) only by purposeful movement of a limb toward noxious stimuli and/or grimacing and/or moaning (no verbal response); (2) by nonpurposeful movements, flexion of upper limbs (decortication), or extension of upper limbs (i.e., decerebration); (3) no response to noxious stimuli.
   

Speech.
For the assessment of language/speech, either motor ability such as speaking or writing or sensory ability such as auditory or visual or mixed will be considered. Test for comprehension and response either verbally or nonverbally.

3. Normal: The patient answers all commands and questions, the conversation is fluent, and there is good comprehension of verbal language. If the patient is intubated, the patient can carry out a three-step command.

2. Dysphasia: The patient may have slurred speech (dysarthria) but is still intelligible, is able to follow complex commands but may show hesitancy, may misspell words or make mistakes when reading aloud. The intubated patient can follow a two-step command or can be understood through writing or "reading lips."

1. Aphasia: Expressive aphasia (Broca's) or receptive asphasia (Wernicke's). Broca's: Speech is halting or laborious, omitting connectives, able to comprehend and identify objects by name. Wernicke's: Speech is easy and fluent but with little or no meaning. Inappropriate words are juxtaposed with no insight and jargon is common. May neither understand nor follow commands or may be mute but comprehends. The patient is able to carry out a single-step command.
   
2. Mute: Global aphasia. The patient is unable to comprehend or follow command.
   

Patients should always be scored according to their worst speech deficit (ie., language score or mispronunciation).

Memory.
Testing to include short term and long term, may include digit span, recall, and the spelling of words backward.

3. Normal: The patient is able to recall three words of three at 5 minutes.

2. Mild deficit: The patient is able to recall two of the three words within 5 minutes or three of three with prompting.

1. Moderate deficit: The patient is able to recall one word of three at 5 minutes or two of three with prompting.
   
2. Severe deficit: The patient is unable to recall any words of the three given even with prompting.
   

Cranial nerves
Vision.
Assessment of visual acuity, visual fields, conjugate and convergence of pupils, ocular movements, and pupillary reaction.

3. Normal: No visual loss, normal acuity with correction, normal visual fields (no change from the baseline). Normal extraocular movements, response to threat.

2. Mild deficit: Inattention, partial palsy, partial field cut, a new diplopia, a change in extraocular movements. One modality not elicited (i.e., abnormal extraocular movement).

1. Moderate deficit: Dense hemianopsia and pupillary deviation, monocular hemianopsia. Two modalities absent.
   
2. Severe deficit: Functionally blind (i.e., the patient is able to see only large moving objects such as a hand); the patient does not respond to testing. All modalities abnormal or absent.
   

Cranial nerves.
To assess the cranial nerves for facial motor function—V, VII, XII—as it pertains to the face, tongue movement, and airway protection.

3. Normal: No weakness, facial symmetry. Normal gag reflex, tongue, and facial movement.

2. Mild deficit: One of the areas show weakness, that is, facial asymmetry, poor airway protection.

1. Moderate deficit: Two of the areas tested show weakness, that is, unilateral facial paralysis.
   
2. Severe deficit: All of the areas tested show weakness, that is, dense facial palsy, loss of gag reflex, and unable to protect the airway.
   

Motor.
Testing of motor strength, both the upper and lower limbs, right and left sides. When strength or range of movement is being tested, the same resistance and position of pressure application must be submitted to each limb. Motor function can be monitored by the ability of the patient to maintain a fixed posture in the upper or lower limb for 3 to 5 seconds; the observer will alternately place the limb in the desired position.

UPPER LIMBS. Place the arms outstretched at 90 degrees in front of the patient. Equal motor response: The patient can maintain the fixed posture equally in both upper limbs for `a few seconds or withdraws equally on both sides to pain. Unequal motor response: The patient cannot maintain equally on both sides the fixed posture, weakness is noted on one side, or there is an unequal withdrawal to pain. Note side where the withdrawal is not as brisk.

LOWER LIMBS. Flexion to thighs with knees flexed at 90 degrees. Equal motor response: The patient can maintain the fixed posture equally in both lower limbs for a few seconds or withdraws equally on both sides to pain. Unequal motor response: The patient cannot maintain the fixed posture equally on both sides, weakness is noted on one side, or there is an unequal withdraw to pain. Note side where the withdrawal is not as brisk.

In the postoperative period, testing will be modified because of limitations of activity and accessory medical interventions such as intravenous lines and chest tubes. Test both upper and lower limbs, proximal and distal to flexion, extension and appropriate withdrawal. Test using either central stimuli (glabellar pressure) or peripheral stimuli (nailbed pressure) on the very drowsy patient.

UPPER LIMB PROXIMAL. The patient should be tested while in the sitting position if possible. To test, abduct the arms to 90 degrees. If the patient is lying in bed, elevate arms to approximately 45 to 90 degrees. Test strength in both arms simultaneously, resistance being applied to the midpoint between the shoulder and the elbow.

UPPER LIMB DISTAL. The patient is tested in either lying or sitting position with the arms elevated. To test, the patient is asked to make a fist and to extend the wrists. A comparison range of movement in both wrists is made simultaneously. If the patient has full range of motion in both wrists, test strength by applying resistance separately to both fists while stabilizing the arm firmly. Grip strength is also tested in both hands.

LOWER LIMBS. The patient should be lying in the bed for all testing and scored on the worst deficit of either hip flexion or dorsiflexion. Hip flexion: Ask the patient to flex thighs toward the trunk with the knees flexed at 90 degrees. Movement in both thighs is tested separately. Dorsiflexion: Have the patient point the toes and foot upward. Compare both feet simultaneously (i.e., complete or partial movement). In both cases apply resistance alternately to each thigh and foot after full movement has been completed to testing of strength. Dorsal extension: Have the patient extend the toes and foot downward and apply resistance.

3. Normal: No detectable weakness. The patient is able to flex or extend the limb, appropriate withdrawal or localization.

2. Mild weakness: Mild drift, apraxia, normal range of motion against gravity, but succumbs to resistance by observer either partially or totally. Also note the loss of rapid fine movements. Abnormal flexion of the extremity.

1. Moderate weakness: Gross drift. Cannot completely overcome gravity in the range of motion (i.e., partial movement). Abnormal extension of the extremity.
   
2. Severe weakness: Paresis of limb or neglect. Absence of motion in movement tested or only contraction of muscles without actual movement of the limb. No motor response or flaccid.
   

Sensation and cerebellum
Sensation.
Testing of the right and left sides for light touch, temperature, vibration, and position sense. The right and left sides should be assessed separately.

3. Normal: No sensory deficit to any of the modalities tested.

2. Mild deficit: Partial sensory or motor loss, tingling or numbness, inattention, loss of one modality.

1. Moderate deficit: Unable to complete modality, loss of sensation of more than one modality.
   
2. Severe deficit: Total sensory loss of all sensation, no response to painful stimuli.
   

Cerebellar.
Testing includes finger-nose, heel-shin, and rapid tapping, nystagmus, ataxia, and incoordination. Posture should be observed when the patient is sitting or standing.

3. Normal: Intact

2. Mild deficit: Loss of finger-nose, or heel-shin, or tapping: mild ataxia, involving only one limb.

1. Moderate deficit: Loss of two of the modalities; gross ataxia.
   
2. Severe deficit: Severe impairment of cerebellar function to all modalities.
   

Reflexes.
The reflexes to be tested include jaw jerk, biceps, triceps, brachioradialis, knee, ankle, and plantar on both the right and the left sides.

3. Normal: All reflexes are intact; toes downgoing.

2. Mild deficit: One reflex is noted to be different in either the upper or lower limb (i.e., hyperreflexive arm or leg).

1. Moderate deficit: Hyporeflexive or hyperreflexive side (i.e., arm and leg).
   
2. Severe deficit: All reflexes abnormal (i.e., hyperactive in both arms and legs and bilateral upgoing toes) and clonus.
   

Primitive reflexes.
The primitive reflexes tested include grasp, palmomental, glabellar tap, sucking, and snout (pout).

3. Absent: No primitive reflexes observed.

2. One primitive reflex present.

1. Two primitive reflexes present.
   
2. All primitive reflexes present.
   

Gait.
Testing to include stance, gait, and Romberg.

3. Normal: The gait is intact.

2. Mild deficit: Wide-based stance, unsteady on feet, slight hemiparesis.

1. Moderate deficit: Marked hemiparesis; the patient may be able to stand with assistance but would fall if not supported.
   
2. Severe deficit: Unable to stand.
   

Footnotes

From the Department of Anaesthesia, University Hospital, University of Western Ontario,^a and Clinical Trials Resources Group, Robarts Research Institute,^d London, Ontario; the Department of Psychology, Vancouver Hospital and Health Sciences Centre,^b Vancouver, British Columbia; and the Department of Neurology, Civic Hospital,^c University of Ottawa, Ottawa, Ontario, Canada.

References

1. Jones EL, Weintraub WS, Craver JM, Guyton RA, Cohen CL. Coronary bypass surgery: Is the operation different today? J THORAC CARDIOVASC SURG 1991;101:108-15.[Abstract]
   
2. Tuman KJ, McCarthy RJ, Najafi H, et al. Differential effects of advanced age on neurologic and cardiac risks of coronary artery operations. J THORAC CARDIOVASC SURG 1992;104:1510-7.[Abstract]
   
3. Shaw PJ, Bates D, Cartlidge NEF, et al. Neurological and neuropsychological morbidity following major surgery: comparison of coronary artery bypass and peripheral vascular surgery. Stroke 1987;18:700-7.[Abstract/Free Full Text]
   
4. Smith PI. The cerebral complications of coronary artery bypass surgery. Ann R Coll Surg Engl 1988;70:212-6.[Medline]
   
5. Venn G, Klinger L, Smith P, et al. Neuropsychological sequelae of bypass twelve months after coronary artery surgery. Br Heart J 1987;57:565.
   
6. Cosgrove DM, Loop FD, Lytle BW, et al. Primary myocardial revascularization. J THORAC CARDIOVASC SURG 1984;88:677-84.
   
7. Carella F, Travaini G, Contri P, et al. Cerebral complications of bypass surgery: a prospective study. Acta Neurol Scand 1988;77:158-63.[Medline]
   
8. Hammeke TA, Hastings JE. Neuropsychological alterations after cardiac operation. J THORAC CARDIOVASC SURG 1988;96:326-31.[Abstract]
   
9. Townes BD, Bashein G, Hornbein TF, et al. Neurobehavioral outcomes in cardiac operations. J THORAC CARDIOVASC SURG 1989;98:774-82.[Abstract]
   
10. Murkin JM, Farrar JK, Tweed WA, McKenzie FN, Guiraudon G. Cerebral autoregulation and flow/metabolism coupling during hypothermic cardiopulmonary bypass: the influence of PaCO₂. Anesth Analg 1987;66:665-72.
    
11. Prough DS, Stump DA, Roy RC, et al. Response of cerebral blood flow to change in carbon dioxide tension during hypothermic cardiopulmonary bypass. Anesthesiology 1986;64:576-81.[Medline]
    
12. Henriksen L. Brain luxury perfusion during cardiopulmonary bypass in humans: a study of the cerebral blood flow response to changes in CO₂ , O₂ , and blood pressure. J Cereb Blood Flow Metab 1986;6:366-78.[Medline]
    
13. Tranmer BI, Gross CE, Kindt GW, Adey GR. Pulsatile versus nonpulsatile blood flow in the treatment of acute cerebral ischemia. Neurosurgery 1986;19:724-30.[Medline]
    
14. Sorenson HR, Husum B, Waaben J, Anderson K, Anderson LI. Brain microvascular function during cardiopulmonary bypass. J THORAC CARDIOVASC SURG 1987;94:727-32.[Abstract]
    
15. Bashein G, Townes BD, Nessly ML, et al. A randomized study of carbon dioxide management during cardiopulmonary bypass. Anesthesiology 1990;72:7-15.[Medline]
    
16. Henze T, Stephan H, Sonntag H. Cerebral dysfunction following extracorporeal circulation for aortocoronary bypass surgery: no differences in neuropsychological outcome after pulsatile versus nonpulsatile flow. Thorac Cardiovasc Surg 1990;38:65-8.[Medline]
    
17. Stephan H, Weyland A, Kazmaier S, et al. Acid-base management during hypothermic cardiopulmonary bypass does not affect cerebral metabolism but does affect blood flow and neurological outcome. Br J Anaesth 1992;69:51-7.[Abstract/Free Full Text]
    
18. Patel RL, Newman S, Turtle MRJ, Chambers DJ, Venn GE. Improved neuropsychological outcome following cardiopulmonary bypass using alpha-stat acid-base management. Ann Thorac Surg [In press].
    
19. Murkin JM, Martzke JS, Buchan AM, Bentley C, Wong CJ. A randomized study of the influence of perfusion technique and pH management strategy in 316 patients undergoing coronary artery bypass surgery. I. Mortality and cardiovascular morbidity. J THORAC CARDIOVASC SURG 1995;110:340-8.[Abstract/Free Full Text]
    
20. Sotaniemi KA, Mononen H, Hokkanen TE. Long-term cerebral outcome after open-heart surgery. Stroke 1986;17:410-6.[Abstract/Free Full Text]
    
21. Benton AL, Hamsher K deS, Varney MR, Spreen O. Contributions to neuropsychological assessment. New York, Oxford University Press, 1983.
    
22. Moody DM, Bell A, Challa VR, Johnstone WE, Prough DS. Brain microemboli during cardiac surgery or aortography. Ann Neurol 1990;28:477-85.[Medline]
    
23. Blauth CI, Smith PL, Arnold JV, Jagoe J, Wootton R, Taylor KM. Influence of oxygenator type on the prevalence and extent of microembolic retinal ischemia during cardiopulmonary bypass. J THORAC CARDIOVASC SURG 1990;99:61-9.[Abstract]
    
24. Pugsley W, Klinger L, Paschalis C, et al. Microemboli and cerebral impairment during cardiac surgery. Vasc Surg 1990;34-43.
    
25. Murkin JM. Temperature measurement and blood gas reporting in studies of hypothermic cardiopulmonary bypass. Anesthesiology 1990;72:100-1.[Medline]
    
26. Padayachee TS, Parsons S, Theobold R, Gosling RG, Deferall PB. The effect of arterial filtration on reduction of gaseous microemboli in the middle cerebral artery during cardiopulmonary bypass. Ann Thorac Surg 1988;45:647-9.[Abstract]
    
27. Prough DS, Stump DA, Troost BT. PaCO₂ management during cardiopulmonary bypass: intriguing physiologic rationale, convincing clinical data, evolving hypothesis? Anesthesiology 1990;72:3-6.[Medline]
    
28. Anstadt MP, Tedder M, Sanjay S, et al. Pulsatile versus nonpulsatile reperfusion improves cerebral blood flow after cardiac arrest. Ann Thorac Surg 1993;56:453-61.[Abstract]
    
29. Taylor KM, Bain WH, Davidson KG, Turner MA. Comparative clinical study of pulsatile and non-pulsatile perfusion in 350 consecutive patients. Thorax 1982;37:324-30.[Abstract/Free Full Text]
    
30. Blauth C, Griffin S, Harrison M, et al. Neuropsychological alterations after cardiac operation [Letter]. J THORAC CARDIOVASC SURG 1989;98:454-5.[Medline]
    
31. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994;125:163-71.[Medline]
    
32. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.[Abstract/Free Full Text]
    
33. Tardiff B, Newman M, Saunders A, et al. Apolipoprotein E allele frequency in patients with cognitive deficits following cardiopulmonary bypass. Circulation [In press].
    

This article has been cited by other articles:

				D. A. Oakes and C. T. M. Mangano Cardiopulmonary Bypass in 2009: Achieving and Circulating Best Practices Anesth. Analg., May 1, 2009; 108(5): 1368 - 1370. [Full Text] [PDF]

				G. S. Murphy, E. A. Hessel II, and R. C. Groom Optimal Perfusion During Cardiopulmonary Bypass: An Evidence-Based Approach Anesth. Analg., May 1, 2009; 108(5): 1394 - 1417. [Abstract] [Full Text] [PDF]

				F. Groenendaal, K. M. K. De Vooght, and F. van Bel Blood Gas Values During Hypothermia in Asphyxiated Term Neonates Pediatrics, January 1, 2009; 123(1): 170 - 172. [Full Text] [PDF]

				K. Maekawa, T. Goto, T. Baba, A. Yoshitake, S. Morishita, and T. Koshiji Abnormalities in the Brain Before Elective Cardiac Surgery Detected by Diffusion-Weighted Magnetic Resonance Imaging Ann. Thorac. Surg., November 1, 2008; 86(5): 1563 - 1569. [Abstract] [Full Text] [PDF]

				T. C. Lisle, K. M. Barrett, L. M. Gazoni, B. R. Swenson, C. D. Scott, A. Kazemi, J. A. Kern, B. B. Peeler, I. L. Kron, and K. C. Johnston Timing of Stroke After Cardiopulmonary Bypass Determines Mortality Ann. Thorac. Surg., May 1, 2008; 85(5): 1556 - 1563. [Abstract] [Full Text] [PDF]

				P. A. Barber, S. Hach, L. J. Tippett, L. Ross, A. F. Merry, and P. Milsom Cerebral Ischemic Lesions on Diffusion-Weighted Imaging Are Associated With Neurocognitive Decline After Cardiac Surgery Stroke, May 1, 2008; 39(5): 1427 - 1433. [Abstract] [Full Text] [PDF]

				J. W. Hammon Extracorporeal Circulation: Perfusion System Card. Surg. Adult, January 1, 2008; 3(2008): 350 - 370. [Full Text]

				J. W. Hammon Extracorporeal Circulation: Organ Damage Card. Surg. Adult, January 1, 2008; 3(2008): 389 - 414. [Full Text]

				R. Pretre and M. I. Turina Deep Hypothermic Circulatory Arrest Card. Surg. Adult, January 1, 2008; 3(2008): 431 - 442. [Full Text]

				F. D. Rubens, M. Boodhwani, T. Mesana, D. Wozny, G. Wells, H. J. Nathan, and on behalf of the Cardiotomy Investigators The Cardiotomy Trial: A Randomized, Double-Blind Study to Assess the Effect of Processing of Shed Blood During Cardiopulmonary Bypass on Transfusion and Neurocognitive Function Circulation, September 11, 2007; 116(11_suppl): I-89 - I-97. [Abstract] [Full Text] [PDF]

				D. K. Harrington, F. Fragomeni, and R. S. Bonser Cerebral Perfusion Ann. Thorac. Surg., February 1, 2007; 83(2): S799 - S804. [Abstract] [Full Text] [PDF]

				J. M. Murkin, S. J. Adams, R. J. Novick, M. Quantz, D. Bainbridge, I. Iglesias, A. Cleland, B. Schaefer, B. Irwin, and S. Fox Monitoring Brain Oxygen Saturation During Coronary Bypass Surgery: A Randomized, Prospective Study Anesth. Analg., January 1, 2007; 104(1): 51 - 58. [Abstract] [Full Text] [PDF]

				T. K. Rosengart, J. J. Sweet, E. Finnin, P. Wolfe, J. Cashy, E. Hahn, J. Marymont, and T. Sanborn Stable Cognition After Coronary Artery Bypass Grafting: Comparisons With Percutaneous Intervention and Normal Controls Ann. Thorac. Surg., August 1, 2006; 82(2): 597 - 607. [Abstract] [Full Text] [PDF]

				K. G. Shann, D. S. Likosky, J. M. Murkin, R. A. Baker, Y. R. Baribeau, G. R. DeFoe, T. A. Dickinson, T. J. Gardner, H. P. Grocott, G. T. O'Connor, et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 283 - 290.e3. [Full Text] [PDF]

				M. Carrier, A. Denault, J. Lavoie, and L. P. Perrault Randomized controlled trial of pericardial blood processing with a cell-saving device on neurologic markers in elderly patients undergoing coronary artery bypass graft surgery. Ann. Thorac. Surg., July 1, 2006; 82(1): 51 - 55. [Abstract] [Full Text] [PDF]

				J. M Murkin Pathophysiological Basis of CNS Injury in Cardiac Surgical Patients: Detection and Prevention Perfusion, July 1, 2006; 21(4): 203 - 208. [Abstract] [PDF]

				S. Al-Ruzzeh, S. George, M. Bustami, J. Wray, C. Ilsley, T. Athanasiou, and M. Amrani Effect of off-pump coronary artery bypass surgery on clinical, angiographic, neurocognitive, and quality of life outcomes: randomised controlled trial BMJ, June 10, 2006; 332(7554): 1365. [Abstract] [Full Text] [PDF]

				G. N. Djaiani Aortic arch atheroma: stroke reduction in cardiac surgical patients. Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2006; 10(2): 143 - 157. [Abstract] [PDF]

				C. W. Hogue Jr, T. Hershey, D. Dixon, R. Fucetola, A. Nassief, K. E. Freedland, B. Thomas, and K. Schechtman Preexisting cognitive impairment in women before cardiac surgery and its relationship with C-reactive protein concentrations. Anesth. Analg., June 1, 2006; 102(6): 1602 - 1608. [Abstract] [Full Text] [PDF]

				S. K. Bhudia, D. M. Cosgrove, R. I. Naugle, J. Rajeswaran, B.-K. Lam, E. Walton, J. Petrich, R. C. Palumbo, A. M. Gillinov, C. Apperson-Hansen, et al. Magnesium as a neuroprotectant in cardiac surgery: A randomized clinical trial J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 853 - 861. [Abstract] [Full Text] [PDF]

				G. M. McKhann, M. A. Grega, L. M. Borowicz Jr, W. A. Baumgartner, and O. A. Selnes Stroke and Encephalopathy After Cardiac Surgery: An Update Stroke, February 1, 2006; 37(2): 562 - 571. [Abstract] [Full Text] [PDF]

				V. I. Chernov, N. Yu. Efimova, I. Yu. Efimova, S. D. Akhmedov, and Y. B. Lishmanov Short-term and long-term cognitive function and cerebral perfusion in off-pump and on-pump coronary artery bypass patients Eur. J. Cardiothorac. Surg., January 1, 2006; 29(1): 74 - 81. [Abstract] [Full Text] [PDF]

				T. K. Rosengart, J. Sweet, E. B. Finnin, P. Wolfe, J. Cashy, E. Hahn, J. Marymont, and T. Sanborn Neurocognitive Functioning in Patients Undergoing Coronary Artery Bypass Graft Surgery or Percutaneous Coronary Intervention: Evidence of Impairment Before Intervention Compared With Normal Controls Ann. Thorac. Surg., October 1, 2005; 80(4): 1327 - 1335. [Abstract] [Full Text] [PDF]

				E. Kozora, C. F. Emery, M. C. Ellison, F. S. Wamboldt, P. T. Diaz, and B. Make Improved Neurobehavioral Functioning in Emphysema Patients Following Lung Volume Reduction Surgery Compared With Medical Therapy Chest, October 1, 2005; 128(4): 2653 - 2663. [Abstract] [Full Text] [PDF]

				J. C. Halstead, D. Spielvogel, D. M. Meier, D. Weisz, C. Bodian, N. Zhang, and R. B. Griepp Optimal pH strategy for selective cerebral perfusion Eur. J. Cardiothorac. Surg., August 1, 2005; 28(2): 266 - 273. [Abstract] [Full Text] [PDF]

				S. Preisman, R. Marks, O. Nahtomi-Shick, and A. Sidi Preservation of static and dynamic cerebral autoregulation after mild hypothermic cardiopulmonary bypass Br. J. Anaesth., August 1, 2005; 95(2): 207 - 211. [Abstract] [Full Text] [PDF]

				D. Bainbridge 3-D Imaging for Aortic Plaque Assessment Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2005; 9(2): 163 - 165. [Abstract] [PDF]

				E. A Black, S. Ghosh, K. Sin, T. Spyt, and R. Pillai Off-Pump Coronary Artery Bypass Surgery Asian Cardiovasc Thorac Ann, December 1, 2004; 12(4): 379 - 386. [Abstract] [Full Text] [PDF]

				S. Bar-Yosef, M. Anders, G. B. Mackensen, L. K. Ti, J. P. Mathew, B. Phillips-Bute, R. H. Messier, H. P. Grocott, and the Neurological Outcome Research Group and CARE I Aortic Atheroma Burden and Cognitive Dysfunction After Coronary Artery Bypass Graft Surgery Ann. Thorac. Surg., November 1, 2004; 78(5): 1556 - 1562. [Abstract] [Full Text] [PDF]

				J. P. Gold, K. E. Torres, W. Maldarelli, I. Zhuravlev, D. Condit, and J. Wasnick Improving Outcomes in Coronary Surgery: The Impact of Echo-Directed Aortic Cannulation and Perioperative Hemodynamic Management in 500 Patients Ann. Thorac. Surg., November 1, 2004; 78(5): 1579 - 1585. [Abstract] [Full Text] [PDF]

				K. Ohkura, T. Kazui, S. Yamamoto, K. Yamashita, H. Terada, N. Washiyama, T. Suzuki, K. Suzuki, M. Fujie, and K. Ohishi Comparison of pH management during antegrade selective cerebral perfusion in canine models with old cerebral infarction J. Thorac. Cardiovasc. Surg., September 1, 2004; 128(3): 378 - 385. [Abstract] [Full Text] [PDF]

				J. W. Hammon Risk Factors for Cardiac Surgery: The High-Risk Patient Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2004; 8(1): 15 - 17. [Abstract] [PDF]

				A. H. Menkis Management of the Ascending Aorta in Routine Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2004; 8(1): 19 - 24. [Abstract] [PDF]

				J. M. Murkin Retrograde cerebral perfusion: more risk than benefit? J. Thorac. Cardiovasc. Surg., September 1, 2003; 126(3): 631 - 633. [Full Text] [PDF]

				Z. L. Nagy, M. Collins, T. Sharpe, S. Mirsadraee, R. R. Guerrero, J. Gibbs, and K. G. Watterson Effect of Two Different Bypass Techniques on the Serum Troponin-T Levels in Newborns and Children: Does pH-Stat Provide Better Protection? Circulation, August 5, 2003; 108(5): 577 - 582. [Abstract] [Full Text] [PDF]

				O. A. Selnes, M. A. Grega, L. M. Borowicz Jr, R. M. Royall, G. M. McKhann, and W. A. Baumgartner Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgical controls Ann. Thorac. Surg., May 1, 2003; 75(5): 1377 - 1386. [Abstract] [Full Text] [PDF]

				H. T. Kiziltan, M. Baltali, A. Bilen, G. Seydaoglu, M. Incesoz, A. Tasdelen, and S. Aslamaci Comparison of Alpha-Stat and pH-Stat Cardiopulmonary Bypass in Relation to Jugular Venous Oxygen Saturation and Cerebral Glucose-Oxygen Utilization Anesth. Analg., March 1, 2003; 96(3): 644 - 650. [Abstract] [Full Text] [PDF]

				J. Vaage and R. Anderson Biochemical markers of neurologic injury in cardiac surgery: The rise and fall of S100{beta} J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(90030): S31 - 33. [Full Text] [PDF]

				E. A. Hessel II and L. H. Edmunds Jr. Extracorporeal Circulation: Perfusion Systems Card. Surg. Adult, January 1, 2003; 2(2003): 317 - 338. [Full Text]

				J. W. Hammon Jr. and L. H. Edmunds Jr. Extracorporeal Circulation: Organ Damage Card. Surg. Adult, January 1, 2003; 2(2003): 361 - 388. [Full Text]

				R. Pretre and M. I. Turina Deep Hypothermic Circulatory Arrest Card. Surg. Adult, January 1, 2003; 2(2003): 401 - 412. [Full Text]

				T. W. Willcox and R. van Uden Best Practice for Cardiopulmonary Bypass in the High-Risk Elderly Patient Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2002; 6(4): 293 - 300. [Abstract] [PDF]

				C. Bartels, A. Gerdes, J. Babin-Ebell, F. Beyersdorf, U. Boeken, T. Doenst, P. Feindt, M. Heiermann, C. Schlensak, and H.-H. Sievers Cardiopulmonary bypass: Evidence or experience based? J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 20 - 27. [Abstract] [Full Text] [PDF]

				F. M. Fouad-Tarazi, J. Feldschuh, S. M. F. Malheiros, A. R. Massaro, E. Buffolo, D. Venes, W. T. C. Yuh, C. J. Knott-Craig, M. D. Tilak, D. van Dijk, et al. Cognitive Outcomes Following Cardiopulmonary Bypass JAMA, June 19, 2002; 287(23): 3077 - 3079. [Full Text] [PDF]

				D. Van Dijk, E. W. L. Jansen, R. Hijman, A. P. Nierich, J. C. Diephuis, K. G. M. Moons, J. R. Lahpor, C. Borst, A. M. A. Keizer, H. M. Nathoe, et al. Cognitive Outcome After Off-Pump and On-Pump Coronary Artery Bypass Graft Surgery: A Randomized Trial JAMA, March 20, 2002; 287(11): 1405 - 1412. [Abstract] [Full Text] [PDF]

				J. M. Murkin, W. D. Boyd, S. Ganapathy, S. J. Adams, R. C. Peterson, J. Morgan, and P. Lok Neuroprotection During CPB: From Mechanisms to Interventions Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2002; 6(1): 3 - 6. [Abstract] [PDF]

				J. M. Murkin Neurologic Monitoring During Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2002; 6(1): 35 - 38. [Abstract] [PDF]

				A. M. Grigore, H. P. Grocott, J. P. Mathew, B. Phillips-Bute, T. O. Stanley, A. Butler, K. P. Landolfo, J. G. Reves, J. A. Blumenthal, and M. F. Newman The Rewarming Rate and Increased Peak Temperature Alter Neurocognitive Outcome After Cardiac Surgery Anesth. Analg., January 1, 2002; 94(1): 4 - 10. [Abstract] [Full Text] [PDF]

				R. P. Alston, K. Yoshitani, M. Kawaguch, H. Furuya, and N. Kurumatani Cerebral Oxygenation and Cognitive Decline Anesth. Analg., December 1, 2001; 93(6): 1628 - 1628. [Full Text] [PDF]

				J. M. Murkin Adverse Central Nervous System Outcomes After Cardiopulmonary Bypass: A Beneficial Effect of Aprotinin? Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2001; 5(4): 282 - 285. [Abstract] [PDF]

				W. A. L. Soong, S. Uysal, and D. L. Reich Cerebral Protection During Surgery of the Aortic Arch Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2001; 5(4): 286 - 292. [Abstract] [PDF]

				J. Vaage and R. Anderson Biochemical markers of neurologic injury in cardiac surgery: The rise and fall of S100{beta} J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 853 - 855. [Full Text] [PDF]

				J. M. Murkin Attenuation of neurologic injury during cardiac surgery Ann. Thorac. Surg., November 1, 2001; 72(5): S1838 - 1844. [Abstract] [Full Text] [PDF]

				M. J. A. Robson, R. P. Alston, I. J. Deary, P. J. D. Andrews, and M. J. Souter Jugular Bulb Oxyhemoglobin Desaturation, S100{beta}, and Neurologic and Cognitive Outcomes After Coronary Artery Surgery Anesth. Analg., October 1, 2001; 93(4): 839 - 845. [Abstract] [Full Text] [PDF]

				S. J. Fearn, R. Pole, K. Wesnes, E. B. Faragher, T. L. Hooper, and C. N. McCollum Cerebral injury during cardiopulmonary bypass: Emboli impair memory J. Thorac. Cardiovasc. Surg., June 1, 2001; 121(6): 1150 - 1160. [Abstract] [Full Text] [PDF]

				K. Yoshitani, M. Kawaguchi, N. Sugiyama, M. Sugiyama, S. Inoue, T. Sakamoto, K. Kitaguchi, and H. Furuya The Association of High Jugular Bulb Venous Oxygen Saturation with Cognitive Decline After Hypothermic Cardiopulmonary Bypass Anesth. Analg., June 1, 2001; 92(6): 1370 - 1376. [Abstract] [Full Text] [PDF]

				R. E. Anderson, L.-O. Hansson, O. Nilsson, J. Liska, G. Settergren, and J. Vaage Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources Ann. Thorac. Surg., May 1, 2001; 71(5): 1512 - 1517. [Abstract] [Full Text] [PDF]

				M. A. Borger, C. M. Peniston, R. D. Weisel, M. Vasiliou, R. E. A. Green, and C. M. Feindel Neuropsychologic impairment after coronary bypass surgery: Effect of gaseous microemboli during perfusionist interventions J. Thorac. Cardiovasc. Surg., April 1, 2001; 121(4): 743 - 749. [Abstract] [Full Text] [PDF]

				M. A. Priestley, J. A. Golden, I. B. O'Hara, J. McCann, and C. D. Kurth Comparison of neurologic outcome after deep hypothermic circulatory arrest with alpha-stat and pH-stat cardiopulmonary bypass in newborn pigs J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0336 - 343. [Abstract] [Full Text] [PDF]

				D. C. Bellinger, D. Wypij, A. J. du Plessis, L. A. Rappaport, J. Riviello, R. A. Jonas, and J. W. Newburger Developmental and neurologic effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0374 - 383. [Abstract] [Full Text] [PDF]

				M. Czerny, H. Baumer, J. Kilo, A. Zuckermann, G. Grubhofer, O. Chevtchik, E. Wolner, and M. Grimm Complete revascularization in coronary artery bypass grafting with and without cardiopulmonary bypass Ann. Thorac. Surg., January 1, 2001; 71(1): 165 - 169. [Abstract] [Full Text] [PDF]

				M. J. A. Robson, R. P. Alston, I. J. Deary, P. J. D. Andrews, M. J. Souter, and S. Yates Cognition After Coronary Artery Surgery Is Not Related to Postoperative Jugular Bulb Oxyhemoglobin Desaturation Anesth. Analg., December 1, 2000; 91(6): 1317 - 1326. [Abstract] [Full Text] [PDF]

				D. van Dijk, A. M. A. Keizer, J. C. Diephuis, C. Durand, L. J. Vos, and R. Hijman Neurocognitive dysfunction after coronary artery bypass surgery: A systematic review J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 632 - 639. [Abstract] [Full Text] [PDF]

				M. Grimm, M. Czerny, H. Baumer, J. Kilo, C. Madl, L. Kramer, A. Rajek, and E. Wolner Normothermic cardiopulmonary bypass is beneficial for cognitive brain function after coronary artery bypass grafting - a prospective randomized trial Eur. J. Cardiothorac. Surg., September 1, 2000; 18(3): 270 - 275. [Abstract] [Full Text] [PDF]

				M. F. Newman, T. O. Stanley, and H. P. Grocott Strategies to Protect the Brain During Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 53 - 64. [Abstract] [PDF]

				J. M. Murkin Central Nervous System Complications in Cardiac Surgery: Retrograde Cerebral Perfusion, Pressure, Pulsatility, Temperature, and pH Management During Cardiopulmonary Bypass Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 65 - 69. [Abstract] [PDF]

				T. Goto, T. Baba, A. Yoshitake, Y. Shibata, M. Ura, and R. Sakata Craniocervical and aortic atherosclerosis as neurologic risk factors in coronary surgery Ann. Thorac. Surg., March 1, 2000; 69(3): 834 - 840. [Abstract] [Full Text] [PDF]

				R. E. Anderson, L.-O. Hansson, J. Liska, G. Settergren, and J. Vaage The effect of cardiotomy suction on the brain injury marker S100{beta} after cardiopulmonary bypass Ann. Thorac. Surg., March 1, 2000; 69(3): 847 - 850. [Abstract] [Full Text] [PDF]

				W. A. C. Mutch, R. K. Warrian, G. M. Eschun, L. G. Girling, L. Doiron, M. S. Cheang, and G. R. Lefevre Biologically variable pulsation improves jugular venous oxygen saturation during rewarming Ann. Thorac. Surg., February 1, 2000; 69(2): 491 - 497. [Abstract] [Full Text] [PDF]

				S NEWMAN and J STYGALL Changes in cognition following cardiac surgery Heart, November 1, 1999; 82(5): 541 - 542. [Full Text]

				K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery) J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347. [Full Text] [PDF]

				J. M. Murkin, W. D. Boyd, S. Ganapathy, S. J. Adams, and R. C. Peterson Beating heart surgery: why expect less central nervous system morbidity? Ann. Thorac. Surg., October 1, 1999; 68(4): 1498 - 1501. [Abstract] [Full Text] [PDF]

				Y. Kadoi, F. Kawahara, S. Saito, T. Morita, F. Kunimoto, F. Goto, and N. Fujita Effects of hypothermic and normothermic cardiopulmonary bypass on brain oxygenation Ann. Thorac. Surg., July 1, 1999; 68(1): 34 - 39. [Abstract] [Full Text] [PDF]

				O. A. Selnes, M. A. Goldsborough, L. M. Borowicz Jr, C. Enger, S. A. Quaskey, and G. M. McKhann Determinants of cognitive change after coronary artery bypass surgery: a multifactorial problem Ann. Thorac. Surg., June 1, 1999; 67(6): 1669 - 1676. [Abstract] [Full Text] [PDF]

				R. E. Anderson, L.-O. Hansson, and J. Vaage Release of S100B during coronary artery bypass grafting is reduced by off-pump surgery Ann. Thorac. Surg., June 1, 1999; 67(6): 1721 - 1725. [Abstract] [Full Text] [PDF]

				J. M. Murkin Strategies and Techniques for Neuroprotection in Coronary Artery Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1999; 3(1): 4 - 8. [Abstract] [PDF]

				C. W. Hogue JR, B. Barzilai, and V. G. Davila-Roman Stroke Reduction: Diagnosis and Management of the Atherosclerotic Ascending Aorta During Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1999; 3(1): 17 - 24. [Abstract] [PDF]

				G. M. McKhann, M. A. Goldsborough, L. M. Borowicz JR, C. Enger, S. Quaskey, and O. A. Selnes Neurobehavioral Outcomes of Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1999; 3(1): 25 - 29. [Abstract] [PDF]

				M. F. Newman, D. T. Laskowitz, A. M. Saunders, A. M. Grigore, and H. P. Grocott Genetic Predictors of Perioperative Neurologic and Neuropsychological Injury and Recovery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1999; 3(1): 34 - 46. [Abstract] [PDF]

				D. A. Stump, W. R. Brown, D. M. Moody, K. D. Rorie, J. C. Manuel, N. D. Kon, J. B. Butterworth, and J. W. Hammon Microemboli and Neurologic Dysfunction After Cardiovascular Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1999; 3(1): 47 - 54. [Abstract] [PDF]

				R. A Jonas Optimal pH strategy for cardiopulmonary bypass in neonates, infants and children Perfusion, December 1, 1998; 13(6): 377 - 387. [PDF]

				A. J. du Plessis, R. A. Jonas, D. Wypij, P. R. Hickey, J. Riviello, D. L. Wessel, S. J. Roth, F. A. Burrows, G. Walter, D. M. Farrell, et al. PERIOPERATIVE EFFECTS OF ALPHA-STAT VERSUS pH-STAT STRATEGIES FOR DEEP HYPOTHERMIC CARDIOPULMONARY BYPASS IN INFANTS J. Thorac. Cardiovasc. Surg., December 1, 1997; 114(6): 991 - 1001. [Abstract] [Full Text]

				E. J. Heyer, D. C. Adams, E. Delphin, D. J. McMahon, S. D. Steneck, M. C. Oz, R. E. Michler, and E. A. Rose CEREBRAL DYSFUNCTION AFTER CORONARY ARTERY BYPASS GRAFTING DONE WITH MILD OR MODERATE HYPOTHERMIA J. Thorac. Cardiovasc. Surg., August 1, 1997; 114(2): 270 - 277. [Abstract] [Full Text]

				A. J. du Plessis Topical Review: Cerebral Hemodynamics and Metabolism During Infant Cardiac Surgery. Mechanisms of Injury and Strategies for Protection J Child Neurol, August 1, 1997; 12(5): 285 - 300. [Abstract] [PDF]

				J. W. Hammon Jr, D. A. Stump, N. D. Kon, A. R. Cordell, A. S. Hudspeth, T. E. Oaks, R. F. Brooker, A. T. Rogers, R. Hilbawi, L. H. Coker, et al. Risk Factors and Solutions for the Development of Neurobehavioral Changes After Coronary Artery Bypass Grafting Ann. Thorac. Surg., June 1, 1997; 63(6): 1613 - 1617. [Abstract] [Full Text]

				J. M. Murkin Alpha-stat acid-base regulation during cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., March 1, 1997; 113(3): 619 - 619. [Full Text]

				D. J. Chambers Alpha-stat acid-base regulation during cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., March 1, 1997; 113(3): 619 - 620. [Full Text]

				J. M. Murkin, J. S. Martzke, A. M. Buchan, C. Bentley, and C. J. Wong A RANDOMIZED STUDY OF THE INFLUENCE OF PERFUSION TECHNIQUE AND pH MANAGEMENT STRATEGY IN 316 PATIENTS UNDERGOING CORONARY ARTERY BYPASS SURGERY:I. Mortality and cardiovascular morbidity J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 340 - 348. [Abstract] [Full Text]

This Article Abstract Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murkin, J. M. Articles by Wong, C. J. Search for Related Content PubMed PubMed Citation Articles by Murkin, J. M. Articles by Wong, C. J.